Log In
Print
BCIQ
Print
Print this Print this
 

AzaSite Xtra (ISV-405)

  Manage Alerts
Collapse Summary General Information
Company InSite Vision Inc.
DescriptionDurasite formulation of azithromycin (2%)
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat ocular infections
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today